China Partnering 2013: Follow the Growth
Posted: June 27, 2013
By: ChinaBio LLC
As the 3rd largest and fastest growing pharma market, China is attracting companies from around the world to launch their products there. And the easiest way to enter China's pharma market is with a China-based company as a partner. This has driven partnering activity to more than double in the last five years to 101 partnerships in 2012, with cross-border partnerships representing 89% of the deals. This white paper examines trends in partnering in China from ChinaBio's proprietary database of 338 partnering and JV deals from 2008 through 2012, and reviews various approaches to partnering and the relative costs, risks and benefits.
Share this content with your network.
By clicking this 'Download Now' box, you consent to BioCentury forwarding your information
to the company that wrote this White Paper and you agree that said company can use